Industry news regarding Stem Cell Treatment. Increasing medical cost and advances in stem research will forces more people to seek the less invasive treatments of stem cell therapy. LAHO/GSCG has positioned itself to take full advantage of this.
...Dr Richard Webb, Research Scientist for SCRABEL, said: “The NHS has identified key challenges it will face in the near future due to an aging population. One of those is the substantial cost conditions like arthritis will have upon the NHS budget due to a rise in the number of older people needing hip or knee replacements.
"Arthritis UK estimate that from now to 2030 the cost to the NHS for people with arthritis needing hip or knee replacement could rise from £3.4 billion to £18.6 billion. Stem cell treatments, like those we are working on, could provide an alternative, cheaper and quicker recovery option for 1000s of people.”...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.